Original language | English |
---|---|
Pages (from-to) | 8-9 |
Number of pages | 2 |
Journal | The Lancet Infectious Diseases |
Volume | 14 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2014 |
Bibliographical note
Funding Information:SHL has received research grants, travel bursaries, speakers honoraria, and support for HIV & hepatitis drug interaction websites from Merck, Janssen, Gilead Sciences, BristolMyersSquibb, Boehringer Ingelheim, AbbVie, and ViiV Healthcare. JPC is Director of the US Critical Illness and Injury Trials Group, and receives some salary support and contract funding from the US Government's Office of the Assistant Secretary for Preparedness and Response. The other authors declare that they have no conflicts of interest.